This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (403)

Published on in Vol 11, No 9 (2022): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/40025, first published .
Melatonin for Neuropathic Pain: Protocol for a Double-blind, Randomized Controlled Trial

Melatonin for Neuropathic Pain: Protocol for a Double-blind, Randomized Controlled Trial

Melatonin for Neuropathic Pain: Protocol for a Double-blind, Randomized Controlled Trial

Authors of this article:

Ian Gilron1 Author Orcid Image ;   Dongsheng Tu2 Author Orcid Image ;   Ronald R Holden2 Author Orcid Image ;   Dwight E Moulin3 Author Orcid Image ;   Scott Duggan1 Author Orcid Image ;   Roumen Milev2 Author Orcid Image
Article Authors Cited by (5) Tweetations (3) Metrics

Journals

  1. Loeffler D, Ihara M. Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems. Journal of Alzheimer's Disease 2024;100(2):379 View
  2. Tong S, Greenberg J, Marini C, Seixas A, Doan L, Osorio R, Thawani S. Disordered Sleep and Painful Diabetic Neuropathy (PDN): a Review of the Literature on Pathophysiology, Pharmacologic and Nonpharmacologic Treatment Options, and Future Directions. Current Sleep Medicine Reports 2025;11(1) View
  3. Gilron I, Elkerdawy H, Tu D, Holden R, Moulin D, Duggan S, Milev R. Melatonin for neuropathic pain: a double-blind, placebo-controlled, randomized, crossover trial. Pain 2025;166(11):2541 View
  4. Jang S, Choi J, Lim H, Kim H, Yoo Y. Comparative Analysis of Melatonin and Polydeoxyribonucleotide: Possible Benefits of Co-Treatment Effects and Potential Synergistic Applicability. International Journal of Molecular Sciences 2025;26(12):5703 View
  5. Kuthati Y, Rao V, Mende L, Wong C. Therapeutic potential of melatonin in management of diabetic mellitus and diabetic neuropathic pain: Underlying mechanisms, challenges and future perspectives. Journal of the Formosan Medical Association 2025 View